The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback
Australia’s Economic Growth Slows in Q3 Despite Strong Investment Activity
Spain’s Industrial Output Records Steady Growth in October Amid Revised September Figures
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
Visa to Move European Headquarters to London’s Canary Wharf
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift 



